• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heparin-Induced Thrombocytopenia.

作者信息

Frazer Cynthia A

机构信息

Eastern Kentucky University, Department of Associate Degree Nursing, Richmond, Kentucky. Cynthia A. Frazer, MS, RN, CNE, CMSRN, is an associate professor in the department of associate degree nursing at Eastern Kentucky University where she teaches medical-surgical nursing.

出版信息

J Infus Nurs. 2017 Mar/Apr;40(2):98-100. doi: 10.1097/NAN.0000000000000215.

DOI:10.1097/NAN.0000000000000215
PMID:28248809
Abstract

Heparin-induced thrombocytopenia (HIT) is an immune-mediated complication of heparin therapy. The use of heparin to flush some vascular access devices makes HIT a concern for infusion nurses. This article reviews the risk factors for, pathophysiology of, and management of HIT.

摘要

相似文献

1
Heparin-Induced Thrombocytopenia.
J Infus Nurs. 2017 Mar/Apr;40(2):98-100. doi: 10.1097/NAN.0000000000000215.
2
An overview of heparin-induced thrombocytopenia.肝素诱导的血小板减少症概述。
J Pharm Pract. 2010 Jun;23(3):226-34. doi: 10.1177/0897190010362171. Epub 2010 Apr 13.
3
Heparin-induced thrombocytopenia: an update.肝素诱导的血小板减少症：最新进展。
Semin Thromb Hemost. 2012 Jul;38(5):483-96. doi: 10.1055/s-0032-1306432. Epub 2012 Mar 7.
4
Heparin-induced thrombocytopenia: pathophysiology and management.肝素诱导的血小板减少症：病理生理学与管理
Vasc Endovascular Surg. 2002 May-Jun;36(3):163-70. doi: 10.1177/153857440203600302.
5
Heparin-induced thrombocytopenia: clinical manifestations and management strategies.肝素诱导的血小板减少症：临床表现及管理策略
Am J Med. 2005 Aug;118 Suppl 8A:21S-30S. doi: 10.1016/j.amjmed.2005.06.005.
6
[Anticoagulation for HIT II: When should it be used therapeutically and when as prophylaxis?].[肝素诱导的血小板减少症的抗凝治疗II：何时应进行治疗性抗凝，何时进行预防性抗凝？]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2002 Apr;37 Suppl 1:S3-7. doi: 10.1055/s-2002-25156.
7
Heparin-induced thrombocytopenia: pathophysiology.
Semin Vasc Surg. 1996 Dec;9(4):284-91.
8
Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia.在存在急性肝素诱导的血小板减少症的情况下，使用肝素抗凝进行心脏移植和/或机械循环支持设备放置。
J Heart Lung Transplant. 2010 Jan;29(1):53-60. doi: 10.1016/j.healun.2009.08.016. Epub 2009 Oct 9.
9
[Heparin-induced thrombocytopenia].[肝素诱导的血小板减少症]
Vnitr Lek. 1996 Oct;42(10):705-9.
10
The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.肝素诱导的血小板减少症的病理生理学：治疗的生物学基础。
Chest. 2005 Feb;127(2 Suppl):9S-20S. doi: 10.1378/chest.127.2_suppl.9S.

引用本文的文献

1
Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis.阿加曲班治疗肝素诱导的血小板减少症的疗效更佳：贝叶斯网状meta 分析。
Int J Clin Pharm. 2021 Aug;43(4):825-838. doi: 10.1007/s11096-021-01260-z. Epub 2021 Mar 28.
2
Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?替格瑞洛能否用于预防新型冠状病毒肺炎（COVID-19）中的脓毒症诱导的凝血病？
Clin Immunol. 2020 Jul;216:108468. doi: 10.1016/j.clim.2020.108468. Epub 2020 May 21.